NCT01636362View on ClinicalTrials.gov

A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
BurnsWound Healing
Interventions
DEVICE

Mepitel Ag

Mepitel Ag is an antimicrobial, meshed, non-adherent wound contact layer allowing passage of exudate and providing fixation and protection of tissues.

Trial Locations (6)

19134

S:t Christopher's Hospital for Children, Philadelphia

32806

Orlando Regional Medical Center, Orlando

46202

Wishard, Indianapolis

73116

Paul Silverstein, MD, Oklahoma City

85008

Arizona Burn Center, Phoenix

98104

Harborview Medical Center, Seattle

All Listed Sponsors
lead

Molnlycke Health Care AB

INDUSTRY

NCT01636362 - A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns | Biotech Hunter | Biotech Hunter